×
Memantine for Agitation/Aggression and Psychosis in Moderately Severe to Severe Alzheimer's Disease: A Pooled Analysis of 3 Studies PDF
$ 40.00
Memantine for Agitation/Aggression and Psychosis in Moderately Severe to Severe Alzheimer's Disease: A Pooled Analysis of 3 Studies PDF quantity
$ 40.00
×
Differences in Prescription Stimulant Misuse Motives Across Adolescents and Young Adults in the United States PDF
$ 40.00
Differences in Prescription Stimulant Misuse Motives Across Adolescents and Young Adults in the United States PDF quantity
$ 40.00
×
Co-Occurrence of Major Depressive Episode and Posttraumatic Stress Disorder Among Survivors of War: How Is It Different From Either Condition Alone? PDF
$ 40.00
Co-Occurrence of Major Depressive Episode and Posttraumatic Stress Disorder Among Survivors of War: How Is It Different From Either Condition Alone? PDF quantity
$ 40.00
×
The Fundamental Structure of Axis II Personality Disorders Assessed in the National Epidemiologic Survey on Alcohol and Related Conditions PDF
$ 40.00
The Fundamental Structure of Axis II Personality Disorders Assessed in the National Epidemiologic Survey on Alcohol and Related Conditions PDF quantity
$ 40.00
×
Randomized, Double-Blind Comparison of Sertraline and Placebo for Posttraumatic Stress Disorder in a Department of Veterans Affairs Setting PDF
$ 40.00
Randomized, Double-Blind Comparison of Sertraline and Placebo for Posttraumatic Stress Disorder in a Department of Veterans Affairs Setting PDF quantity
$ 40.00
×
Efficacy and Safety of Deep Brain Stimulation in Patients With Medication-Induced Tardive Dyskinesia and/or Dystonia: A Systematic Review PDF
$ 40.00
Efficacy and Safety of Deep Brain Stimulation in Patients With Medication-Induced Tardive Dyskinesia and/or Dystonia: A Systematic Review PDF quantity
$ 40.00
×
Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder PDF
$ 40.00
Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder PDF quantity
$ 40.00
×
Categorical and Dimensional Stability of Comorbid Personality Disorder Symptoms in DSM-IV Major Depressive Disorder: A Prospective Study PDF
$ 40.00
Categorical and Dimensional Stability of Comorbid Personality Disorder Symptoms in DSM-IV Major Depressive Disorder: A Prospective Study PDF quantity
$ 40.00
×
Psychiatric Comorbidity as a Predictor of Clinical Response to Nortriptyline in Treatment-Resistant Major Depressive Disorder PDF
$ 40.00
Psychiatric Comorbidity as a Predictor of Clinical Response to Nortriptyline in Treatment-Resistant Major Depressive Disorder PDF quantity
$ 40.00
×
Buspirone in the Management of Anxiety and Irritability in Children With Pervasive Developmental Disorders: Results of an Open-Label Study PDF
$ 40.00
Buspirone in the Management of Anxiety and Irritability in Children With Pervasive Developmental Disorders: Results of an Open-Label Study PDF quantity
$ 40.00
×
Gepirone Extended-Release: New Evidence for Efficacy in the Treatment of Major Depressive Disorder PDF
$ 40.00
Gepirone Extended-Release: New Evidence for Efficacy in the Treatment of Major Depressive Disorder PDF quantity
$ 40.00
×
The Effects of Mirtazapine on Plasma Lipid Profiles in Healthy Subjects PDF
$ 40.00
The Effects of Mirtazapine on Plasma Lipid Profiles in Healthy Subjects PDF quantity
$ 40.00
×
Sleep Latency Is Shortened During 4 Weeks of Treatment With Zaleplon, a Novel Nonbenzodiazepine Hypnotic PDF
$ 40.00
Sleep Latency Is Shortened During 4 Weeks of Treatment With Zaleplon, a Novel Nonbenzodiazepine Hypnotic PDF quantity
$ 40.00
×
Impact of Once- Versus Twice-Daily Perphenazine Dosing on Clinical Outcomes: An Analysis of the CATIE Data PDF
$ 40.00
Impact of Once- Versus Twice-Daily Perphenazine Dosing on Clinical Outcomes: An Analysis of the CATIE Data PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart